Recent Tech Transfer Deals (09/11)
This article was originally published in Start Up
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
You may also be interested in...
On Target Laboratories’ Cytalux (pafolacianine) is now approved for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions.
The company’s lead candidate, AP1189, has shown promise in a mid-stage rheumatoid arthritis study, sparking plans for an imminent strategic business collaboration.
Owlet Baby Care has stopped selling its Smart Sock baby monitoring device after a five-year fight with the US Food and Drug Administration over whether the product should be regulated as a medical device. The company is now seeking FDA clearance.